| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 10/25/2001 | WO2001079282A2 Molecules associated with human reproduction |
| 10/25/2001 | WO2001079271A1 Albumin fusion proteins |
| 10/25/2001 | WO2001079258A1 Albumin fusion proteins |
| 10/25/2001 | WO2001078796A1 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor |
| 10/25/2001 | WO2001078779A2 Antibody alpha4beta7 integrin and its use to treat inflammatory bowel disease |
| 10/25/2001 | WO2001078768A2 Targeted vaccine delivery systems |
| 10/25/2001 | WO2001078754A2 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof |
| 10/25/2001 | WO2001078713A1 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 10/25/2001 | WO2001078712A1 Substituted styryl benzylsulfones for treating proliferative disorders |
| 10/25/2001 | WO2001078701A2 Method and compositions for preventing hormone induced adverse effects |
| 10/25/2001 | WO2001078698A2 Use of ngf-antagonists for the prevention or treatment of chronic visceral pain |
| 10/25/2001 | WO2001044246A8 Bicyclic inhibitors of glycogen synthase kinase 3 |
| 10/25/2001 | WO2001027113A3 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES |
| 10/25/2001 | WO2001026664A3 Hormone-sensitive lipase activity mediated male infertility |
| 10/25/2001 | WO2001022091A3 Method for determining the fertility of mammals, especially of humans |
| 10/25/2001 | WO2000061541A8 Pharmaceutical compounds |
| 10/25/2001 | US20010034348 Nitric oxide synthase inhibitor; nervous system disorders |
| 10/25/2001 | US20010034340 Hormone replacement therapy |
| 10/25/2001 | US20010034337 Antiproliferative agents |
| 10/25/2001 | US20010034051 For example: (2-(3-amino-4-nitrophenyl)amino)ethyl)(6-(2,4-dichlorophenyl-5-nitropyrazin -2-yl)-amine; antidiabetic, -carcingenic and ischemic agents; nervous and cardiovascular system disorders; immunotherapy; obesity; syndromes |
| 10/25/2001 | CA2747325A1 Albumin fusion proteins |
| 10/25/2001 | CA2406403A1 Tissue-specific and pathogen-specific toxic agents, ribozymes, dnazymes and antisense oligonucleotides, and methods of use thereof |
| 10/25/2001 | CA2406378A1 Targeted vaccine delivery systems |
| 10/25/2001 | CA2406220A1 Antibody alpha4beta7 integrin and its use to treat inflammatory bowel disease |
| 10/25/2001 | CA2405709A1 Albumin fusion proteins |
| 10/25/2001 | CA2405701A1 Albumin fusion proteins |
| 10/25/2001 | CA2405563A1 Albumin fusion proteins |
| 10/25/2001 | CA2405557A1 Albumin fusion proteins |
| 10/25/2001 | CA2405550A1 Albumin fusion proteins |
| 10/25/2001 | CA2405525A1 Albumin fusion proteins |
| 10/25/2001 | CA2405451A1 Molecules associated with human reproduction |
| 10/25/2001 | CA2404127A1 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor |
| 10/25/2001 | CA2404117A1 Use of ngf-antagonists for the prevention or treatment of chronic visceral pain |
| 10/25/2001 | CA2404097A1 Method and compositions for preventing hormone induced adverse effects |
| 10/25/2001 | CA2370572A1 Kv10.1, a novel voltage-gated potassium channel from human brain |
| 10/24/2001 | EP1147776A2 Use of botulinum toxin type B for the manufacture of a medicament for the treatment of muscle spasms |
| 10/24/2001 | EP1147775A2 Use of botulinum toxin type B for the manufacture of a medicament for reducing pain associated with a muscle disorder |
| 10/24/2001 | EP1147223A1 Identifying, monitoring, and treating women for breast precancer or cancer |
| 10/24/2001 | EP1147136A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF |
| 10/24/2001 | EP1147121A2 Ketolide antibiotics |
| 10/24/2001 | EP1147116A1 Boron steroid mimics and pharmaceutical compositions |
| 10/24/2001 | EP1147112A1 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
| 10/24/2001 | EP1147110A1 Pyrazino(aza)indole derivatives |
| 10/24/2001 | EP1147095A1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors |
| 10/24/2001 | EP1147092A1 Substituted imidazoles, their preparation and use |
| 10/24/2001 | EP1147089A1 Phenylphenanthridines with pde-iv inhibiting activity |
| 10/24/2001 | EP1147078A1 Acetylenic (beta)-sulfonamido and phosphinic acid amide hydroxamic acid tace inhibitors |
| 10/24/2001 | EP1146883A1 Modulation of immune response by ribavirin |
| 10/24/2001 | EP1146873A1 Anti-androgens and methods for treating disease |
| 10/24/2001 | EP1146787A1 Methods for identifying, treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer |
| 10/24/2001 | CN1319139A Polynucleotide constructs and uses thereof |
| 10/24/2001 | CN1319094A Imidazolyl derivatives |
| 10/24/2001 | CN1318410A Medicine specially for women's sterility |
| 10/24/2001 | CN1318409A Mastoproliferation treating capsule |
| 10/24/2001 | CN1318400A Medicine for treating spermacrasia and its preparation process |
| 10/24/2001 | CN1318389A Vaginitis-treating compound Chinese and Western medicine preparation |
| 10/24/2001 | CN1318385A Specific compound impotence treating preparation and its preparation |
| 10/24/2001 | CN1318372A Application of insulin sensitizing agent in treatment of nephrosis |
| 10/24/2001 | CN1073557C Vitamin-D amide derivatives |
| 10/24/2001 | CN1073444C 避孕糊剂 Contraception paste |
| 10/24/2001 | CN1073438C Medicine for external application for curing gynecopathy |
| 10/24/2001 | CN1073422C Use of progestin for preparing medicine for reducing endometrorrhagia |
| 10/23/2001 | US6307092 Potent ocular hypotensives and are particularly suited for the management of glaucoma. |
| 10/23/2001 | US6307050 Method of synthesizing flosequinan from 4-fluoroanthranilic acid |
| 10/23/2001 | US6307022 Def |
| 10/23/2001 | US6306914 Progestin therapy for maintaining amenorrhea |
| 10/23/2001 | US6306852 Indole derivatives useful as endothelin receptor antagonists |
| 10/23/2001 | US6306851 Cyclocarbamate and cyclic amide derivatives |
| 10/23/2001 | US6306841 Treatment of female sexual dysfunction |
| 10/23/2001 | US6306827 Method for preventing and/or treating renal disease |
| 10/23/2001 | US6306819 Method for regulating size of vascularized normal tissue |
| 10/23/2001 | US6306654 Nucleotide sequence coding mutant gonadotrophin hormone; for treatment of reproduction defects |
| 10/23/2001 | US6306653 Peptide for use in diagnosis, prevention and treatment of mammary gland cancer |
| 10/23/2001 | US6306437 Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
| 10/23/2001 | CA2236368C Sublingual and buccal administration of selegiline |
| 10/23/2001 | CA2223817C Compositions for the treatment of rheumatoid-based arthritic diseases |
| 10/23/2001 | CA2087606C (2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same |
| 10/18/2001 | WO2001077338A2 Human protein kinases and protein kinase-like enzymes |
| 10/18/2001 | WO2001077335A2 Listeria monocytogenes genome, polypeptides and uses |
| 10/18/2001 | WO2001077327A1 THE HIGH BONE MASS GENE OF 11q13.3 |
| 10/18/2001 | WO2001077298A2 Human müllerian duct-derived epithelial cells and methods of isolation and uses thereof |
| 10/18/2001 | WO2001077294A2 Hpv-specific short-mers |
| 10/18/2001 | WO2001077181A2 Anti-rhesus d monoclonal antibodies |
| 10/18/2001 | WO2001077166A1 Novel physiologically active peptides and use thereof |
| 10/18/2001 | WO2001077146A2 Compounds and methods for modulating endothelial cell adhesion |
| 10/18/2001 | WO2001077139A1 8ss-HYDROCARBYL-SUBSTITUTED ESTRATRIENES FOR USE AS SELECTIVE ESTROGENS |
| 10/18/2001 | WO2001077138A1 8β-SUBSTITUTED-11β-PENTYL- AND 11β-HEXYL-ESTRA-1,3,5(10)-TRIENE DERIVATIVES |
| 10/18/2001 | WO2001077137A1 Albumin fusion proteins |
| 10/18/2001 | WO2001077110A1 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors |
| 10/18/2001 | WO2001077093A1 Estrogen agonist/antagonist metabolites |
| 10/18/2001 | WO2001077087A1 Novel compounds |
| 10/18/2001 | WO2001077085A1 Quinazoline compounds |
| 10/18/2001 | WO2001076602A1 Apomorphine derivatives and methods for their use |
| 10/18/2001 | WO2001076573A2 Combination of at least two compounds selected from an at1-receptor antagonist or an ace inhibitor or a hmg-co-a reductase inhibitor groups |
| 10/18/2001 | WO2001076572A2 Use of compatible solutes as substances having free radical scavenging properties |
| 10/18/2001 | WO2001076568A2 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 10/18/2001 | WO2001076530A2 Il-8 receptor antagonists |
| 10/18/2001 | WO2001076360A2 Synchronization of the cytoplasmatic and the nuclear maturation of oocytes in vitro |
| 10/18/2001 | WO2001023388A3 AMINO SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES |
| 10/18/2001 | US20010031766 Prostaglandin receptor ligands |